Search Bar & Filters
Found 9 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating two approaches to rehabilitation following anterior cruciate ligament reconstruction ACLR in this trial. The study compares standard rehabilitation with Rehabilitation with Exercise and Psychological Support REPS, which combines exercise with psychological support through trained physical therapists and patient training videos. The goal is to see if REPS improves psychological readiness for sport and knee function more than standard rehabilitation in young athletes aged 15 to 25 years. Participants receive exercise therapy based on TRIA rehabilitation protocols for ACL reconstruction using either bone-patellar tendon-bone or quadriceps tendon autografts. Physical therapists in the REPS group receive special training to provide enhanced psychological support. Patients in both groups receive exercise videos online, but only the REPS group receives additional psychological support videos. The study involves a randomized, double-blind design with two groups standard rehabilitation and REPS. Participants attend a total of four study visits over six months one before surgery and three during follow-up after surgery. At each visit, psychological and knee function assessments are conducted using validated questionnaires and clinical tests. Outcome measures include the ACL Return to Sport after Injury scale, International Knee Documentation Committee subjective form, and Tampa Scale for Kinesiophobia. Researchers also evaluate knee pain, range of motion, strength, and functional tests at specified intervals. The study aims to assess the feasibility, acceptability, and effectiveness of integrating psychological support into ACL rehabilitation.
Actively Recruiting
Bone stress injuries BSIs are common overuse injuries in athletes caused by repeated skeletal loading that exceeds bone repair capacity. This study observes male and female runners aged 16 to 35 with MRI-confirmed lower extremity BSIs to better understand how BSIs heal and to improve return-to-sport guidelines. The study aims to identify clinical, functional, imaging, and biological markers associated with recovery and risk of future injuries. Participants continue their usual clinical care while following a standardized return-to-run program developed by clinicians and physical therapists. The study involves an initial visit soon after diagnosis and multiple follow-up assessments varying by injury location. Assessments include symptom and function surveys, clinical severity ratings, repeat MRIs, and monitoring of return-to-run progress via diaries and electronic surveys. Optional data collection from compatible Garmin smartwatches is also included. Throughout the year following injury, participants provide blood samples, complete questionnaires on health and lifestyle factors, and perform single-leg hopping tests to evaluate limb loading. Monthly follow-ups track any additional BSIs. Researchers measure outcomes such as pain-free hopping, jogging durations, return-to-run completion, medical clearance timing, changes in MRI grades, and clinical severity scores. The study monitors recovery patterns and factors influencing healing over a 12-month period.
Actively Recruiting
Researchers are evaluating a new atrioventricular interval modulation AVIM algorithm programmed into a dual-chamber Medtronic AstraAzure pacemaker. This trial is designed to assess the safety and effectiveness of this device-based therapy in patients who have hypertension and either already have or need a dual-chamber pacemaker. The study is randomized, double-blind, and conducted across multiple countries. The study has three phases an initial screening phase, followed by a one-year double-blind randomized phase where participants are assigned to either have the AVIM therapy turned on or off, while continuing their stable antihypertensive medication. After this, there is a two-year unblinded phase for further observation. The investigational AVIM therapy is delivered through the pacemaker device. Participants will be monitored for changes in their 24-hour ambulatory systolic blood pressure and for any unexpected serious adverse effects related to the device. Assessments will be done at baseline and three months after randomization, with ongoing evaluation during the two-year follow-up. The entire study duration can last up to three years, including screening and all treatment phases.
Actively Recruiting
Healthy Volunteer
Researchers are conducting the Helix Research Network study to create a large clinicogenomics dataset by collecting genetic and clinical information from participants. This observational study aims to discover molecular and genetic factors influencing disease risk, progression, treatment response, and other health outcomes. The study also seeks to identify targets for therapies and improve diagnosis and treatment through clinical implementation. Participants will provide samples for exome sequencing, which analyzes the protein-coding regions of genes. The study is open to an unlimited number of individuals recruited from various healthcare systems within the network. Enrollment continues until participants withdraw or the study ends. Participants will receive individual genetic results and annual reports on overall study findings and their impact. Throughout the study, participants will provide data used to identify genetic biomarkers and explore genetic determinants of disease over an average of 10 years. Researchers will collect patient-reported outcomes and may re-contact participants as needed. The study involves ongoing data aggregation and long-term follow-up to support research and improve personalized medical care.
Actively Recruiting
Researchers are evaluating the Persona Revision Knee System in patients who have previously undergone primary or revision total knee arthroplasty TKA. This observational study aims to assess the devices performance, clinical benefits, and safety through a retrospective cohort with prospective follow-up. The study involves patients treated with this knee system at up to 20 sites, with a maximum enrollment of 380 participants. The study includes patients implanted with various configurations of the Persona Revision Knee System, including different tibial stems, tibial components, articular surfaces, and femoral components. Participants are identified retrospectively and then invited to participate in prospective data collection at 1, 2, 3, 4, 5, 7, and 10 years after surgery. The device and any compatible instruments used follow the approved instructions for use. Participants will provide data through scheduled follow-up visits over several years, with assessments including the Knee Society Clinical Rating System objective knee score at 2 years as the primary outcome. Secondary measures include adverse events, pain scores, and knee function scores. The study monitors safety and clinical outcomes over time, with a total participation duration potentially extending up to 10 years postoperatively.
Actively Recruiting
Researchers are evaluating rehabilitation methods following reverse total shoulder arthroplasty RTSA, a surgery used for conditions like rotator cuff arthropathy and shoulder fractures. The study compares immediate active shoulder rehabilitation IASR with the traditional post-operative rehabilitation to understand their effects on pain relief, shoulder function, complications, and cost effectiveness over one year. This trial aims to improve patient health, experience, and reduce healthcare costs following RTSA. Participants are randomly assigned to one of two rehabilitation groups after RTSA surgery. One group starts immediate active shoulder physical therapy from the first day after surgery, including specific stretches and full active shoulder motion. The other group follows a traditional therapy protocol that gradually introduces active shoulder motion starting around week 6, involving about 18 physical therapy visits. Physical therapy sessions take place at a location comfortable for the patient. Throughout the study, participants will be assessed before surgery and at multiple time points up to one year after surgery. Evaluations include shoulder function scores, pain and quality of life questionnaires, and measurements of shoulder range of motion. Researchers will also monitor complications like subscapularis tears. Participants must be willing to complete questionnaires and attend follow-up visits, with results used to determine the overall impact of the rehabilitation methods.
Actively Recruiting
Researchers are evaluating the safety and effectiveness of TARA-002, a biological preparation containing cells of Streptococcus pyogenes, in adults 18 years and older with high-grade non-muscle invasive bladder cancer NMIBC including carcinoma in situ CIS with or without TaT1. This Phase 2 open-label study aims to further assess TARA-002 at the recommended Phase 2 dose established in a prior dose-finding study. Participants include those who are BCG naive, BCG exposed but not recently treated, or BCG unresponsive. Participants will receive intravesical instillations of TARA-002 in a structured treatment schedule. The first period consists of 6 weekly doses. Those eligible for reinduction will receive another 6 weekly doses, while participants with a complete response after the first period will get 3 weekly maintenance doses. A third treatment period includes 3 weekly maintenance doses administered at months 6, 9, 12, 15, 18, and 24. Following treatment, participants enter a follow-up period lasting from month 27 to month 60. Throughout the study, participants will be monitored for tumor response, including high-grade complete response rates and duration, progression-free survival, cystectomy timing, and survival outcomes up to 60 months. Safety assessments include monitoring adverse events and biomarker changes in urine. Quality of life questionnaires will be administered up to 24 months. This comprehensive evaluation aims to understand TARA-002s effects and safety over time in this patient population.
Actively Recruiting
Researchers are evaluating a care pathway designed to prevent suicide by connecting patients to behavioral health services when they are released from jail. The study aims to assess the impact of this intervention on reducing suicide attempts, increasing behavioral health service use, and understanding how the intervention can be implemented effectively and sustainably in health and jail systems. Participants are randomly assigned to one of two groups one group receives an intervention including outreach contacts, suicide risk screening, safety planning, and connection to healthcare services and virtual support if needed. The other group receives usual healthcare services without knowledge of study involvement. This approach helps compare the effectiveness of the intervention versus standard care at the time of jail release. During the study, participants will be monitored for suicide attempts and deaths over six months following jail release. Researchers will evaluate behavioral health service use and gather data on the interventions cost, acceptability, and practicality for future use. The study runs from June 2024 to July 2027, with regular assessments to measure outcomes and implementation success.
Actively Recruiting
Researchers are evaluating the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instruments in patients undergoing primary or revision shoulder arthroplasty. The study aims to confirm implant survival over 10 years, monitor adverse events, and assess improvements in shoulder function, pain, quality of life, and radiographic outcomes using standard scoring systems and imaging. Participants will receive the Zimmer Biomet Total Shoulder Arthroplasty System, including devices like the Alliance Glenoid and Identity Stem, designed for various types of shoulder replacements. The study will follow patients for 10 years to track implant survival and safety, with a 2-year evaluation focusing on clinical performance and radiographic measures. During the study, patients will undergo assessments of implant survival using the Kaplan Meier method, adverse event monitoring, and evaluations of shoulder function with the American Shoulder and Elbow Surgeons ASES score, quality of life questionnaires, and detailed radiographic imaging. Follow-up visits at 2 years and up to 10 years will help researchers understand the long-term results of the shoulder arthroplasty system.